SorLA Controls Neurotrophic Activity by Sorting of GDNF and Its Receptors GFRα1 and RET

Cell Reports

Volumn 3, Issue 1, 2013, Pages 186-199

  Glerup, Simon ^a   Lume, Maria ^b   Olsen, Ditte ^a   Nyengaard, Jens R ^a   Vaegter, Christian B ^a   Gustafsen, Camilla ^a   Christensen, Erik I ^a   Kjolby, Mads ^a   Hay Schmidt, Anders ^c   Bender, Dirk ^a   Madsen, Peder ^a   Saarma, Mart ^b   Nykjaer, Anders ^a   Petersen, Claus M ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR ALPHA1; MEMBRANE PROTEIN; PROTEIN RET; PROTEIN SORLA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CELL SURFACE; CENTRAL NERVOUS SYSTEM; COMPLEX FORMATION; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; ENDOCYTOSIS; ENDOSOME; HUMAN; HUMAN CELL; HYPERACTIVITY; MALE; MOUSE; NEUROTROPISM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN TARGETING; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CELL MEMBRANE; CELL SURVIVAL; DOPAMINERGIC NEURONS; ENDOCYTOSIS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; HEK293 CELLS; HUMANS; LYSOSOMES; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIPROTEIN COMPLEXES; PROTEIN BINDING; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-RET; RECEPTORS, LDL;

MUS;

EID: 84873162291     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2012.12.011     Document Type: Article

References (45)

1. Abeliovich A., Schmitz Y., Fariñas I., Choi-Lundberg D., Ho W.H., Castillo P.E., Shinsky N., Verdugo J.M., Armanini M., Ryan A., et al. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 2000, 25:239-252.
2. Airaksinen M.S., Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat. Rev. Neurosci. 2002, 3:383-394.
3. Andersen O.M., Reiche J., Schmidt V., Gotthardt M., Spoelgen R., Behlke J., von Arnim C.A., Breiderhoff T., Jansen P., Wu X., et al. Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc. Natl. Acad. Sci. USA 2005, 102:13461-13466.
4. Baloh R.H., Tansey M.G., Johnson E.M., Milbrandt J. Functional mapping of receptor specificity domains of glial cell line-derived neurotrophic factor (GDNF) family ligands and production of GFRalpha1 RET-specific agonists. J. Biol. Chem. 2000, 275:3412-3420.
5. Bespalov M.M., Sidorova Y.A., Tumova S., Ahonen-Bishopp A., Magalhães A.C., Kulesskiy E., Paveliev M., Rivera C., Rauvala H., Saarma M. Heparan sulfate proteoglycan syndecan-3 is a novel receptor for GDNF, neurturin, and artemin. J. Cell Biol. 2011, 192:153-169.
6. Burke R.E., Antonelli M., Sulzer D. Glial cell line-derived neurotrophic growth factor inhibits apoptotic death of postnatal substantia nigra dopamine neurons in primary culture. J. Neurochem. 1998, 71:517-525.
7. Carnicella S., Ron D. GDNF-a potential target to treat addiction. Pharmacol. Ther. 2009, 122:9-18.
8. Chen Z.Y., Jing D., Bath K.G., Ieraci A., Khan T., Siao C.J., Herrera D.G., Toth M., Yang C., McEwen B.S., et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006, 314:140-143.
9. Geng Z., Xu F.Y., Huang S.H., Chen Z.Y. Sorting protein-related receptor SorLA controls regulated secretion of glial cell line-derived neurotrophic factor. J. Biol. Chem. 2011, 286:41871-41882.
10. Georgievska B., Kirik D., Björklund A. Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Exp. Neurol. 2002, 177:461-474.
11. Georgievska B., Kirik D., Björklund A. Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system. J. Neurosci. 2004, 24:6437-6445.
12. Gerlai R., McNamara A., Choi-Lundberg D.L., Armanini M., Ross J., Powell-Braxton L., Phillips H.S. Impaired water maze learning performance without altered dopaminergic function in mice heterozygous for the GDNF mutation. Eur. J. Neurosci. 2001, 14:1153-1163.
13. Gill S.S., Patel N.K., Hotton G.R., O'Sullivan K., McCarter R., Bunnage M., Brooks D.J., Svendsen C.N., Heywood P. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med. 2003, 9:589-595.
14. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996, 379:606-612.
15. Grant A., Hoops D., Labelle-Dumais C., Prévost M., Rajabi H., Kolb B., Stewart J., Arvanitogiannis A., Flores C. Netrin-1 receptor-deficient mice show enhanced mesocortical dopamine transmission and blunted behavioural responses to amphetamine. Eur. J. Neurosci. 2007, 26:3215-3228.
16. Himanen J.P., Chumley M.J., Lackmann M., Li C., Barton W.A., Jeffrey P.D., Vearing C., Geleick D., Feldheim D.A., Boyd A.W., et al. Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling. Nat. Neurosci. 2004, 7:501-509.
17. Hirata Y., Kiuchi K. Mitogenic effect of glial cell line-derived neurotrophic factor is dependent on the activation of p70S6 kinase, but independent of the activation of ERK and up-regulation of Ret in SH-SY5Y cells. Brain Res. 2003, 983:1-12.
18. Horger B.A., Nishimura M.C., Armanini M.P., Wang L.C., Poulsen K.T., Rosenblad C., Kirik D., Moffat B., Simmons L., Johnson E., et al. Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons. J. Neurosci. 1998, 18:4929-4937.
19. Ibáñez C.F. Beyond the cell surface: new mechanisms of receptor function. Biochem. Biophys. Res. Commun. 2010, 396:24-27.
20. Jacobsen L., Madsen P., Moestrup S.K., Lund A.H., Tommerup N., Nykjaer A., Sottrup-Jensen L., Gliemann J., Petersen C.M. Molecular characterization of a novel human hybrid-type receptor that binds the alpha2-macroglobulin receptor-associated protein. J. Biol. Chem. 1996, 271:31379-31383.
21. Jacobsen L., Madsen P., Jacobsen C., Nielsen M.S., Gliemann J., Petersen C.M. Activation and functional characterization of the mosaic receptor SorLA/LR11. J. Biol. Chem. 2001, 276:22788-22796.
22. Kirik D., Georgievska B., Björklund A. Localized striatal delivery of GDNF as a treatment for Parkinson disease. Nat. Neurosci. 2004, 7:105-110.
23. Klinger S.C., Glerup S., Raarup M.K., Mari M.C., Nyegaard M., Koster G., Prabakaran T., Nilsson S.K., Kjaergaard M.M., Bakke O., et al. SorLA regulates the activity of lipoprotein lipase by intracellular trafficking. J. Cell Sci. 2011, 124:1095-1105.
24. Koehnke J., Katsamba P.S., Ahlsen G., Bahna F., Vendome J., Honig B., Shapiro L., Jin X. Splice form dependence of beta-neurexin/neuroligin binding interactions. Neuron 2010, 67:61-74.
25. Lang A.E., Gill S., Patel N.K., Lozano A., Nutt J.G., Penn R., Brooks D.J., Hotton G., Moro E., Heywood P., et al. Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann. Neurol. 2006, 59:459-466.
26. Ledda F., Paratcha G., Sandoval-Guzmán T., Ibáñez C.F. GDNF and GFRalpha1 promote formation of neuronal synapses by ligand-induced cell adhesion. Nat. Neurosci. 2007, 10:293-300.
27. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993, 260:1130-1132.
28. Lonka-Nevalaita L., Lume M., Leppänen S., Jokitalo E., Peränen J., Saarma M. Characterization of the intracellular localization, processing, and secretion of two glial cell line-derived neurotrophic factor splice isoforms. J. Neurosci. 2010, 30:11403-11413.
29. Messer C.J., Eisch A.J., Carlezon W.A., Whisler K., Shen L., Wolf D.H., Westphal H., Collins F., Russell D.S., Nestler E.J. Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron 2000, 26:247-257.
30. Michelato A., Bonvicini C., Ventriglia M., Scassellati C., Randazzo R., Bignotti S., Beneduce R., Riva M.A., Gennarelli M. 3' UTR (AGG)n repeat of glial cell line-derived neurotrophic factor (GDNF) gene polymorphism in schizophrenia. Neurosci. Lett. 2004, 357:235-237.
31. Nielsen M.S., Gustafsen C., Madsen P., Nyengaard J.R., Hermey G., Bakke O., Mari M., Schu P., Pohlmann R., Dennes A., Petersen C.M. Sorting by the cytoplasmic domain of the amyloid precursor protein binding receptor SorLA. Mol. Cell. Biol. 2007, 27:6842-6851.
32. Paratcha G., Ledda F., Ibáñez C.F. The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands. Cell 2003, 113:867-879.
33. Pichel J.G., Shen L., Sheng H.Z., Granholm A.C., Drago J., Grinberg A., Lee E.J., Huang S.P., Saarma M., Hoffer B.J., et al. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 1996, 382:73-76.
34. Pozas E., Ibáñez C.F. GDNF and GFRalpha1 promote differentiation and tangential migration of cortical GABAergic neurons. Neuron 2005, 45:701-713.
35. Quistgaard E.M., Madsen P., Grøftehauge M.K., Nissen P., Petersen C.M., Thirup S.S. Ligands bind to Sortilin in the tunnel of a ten-bladed beta-propeller domain. Nat. Struct. Mol. Biol. 2009, 16:96-98.
36. Rosenblad C., Georgievska B., Kirik D. Long-term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system. Eur. J. Neurosci. 2003, 17:260-270.
37. Sajadi A., Bauer M., Thöny B., Aebischer P. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production. J. Neurochem. 2005, 93:1482-1486.
38. Sieber B.A., Kuzmin A., Canals J.M., Danielsson A., Paratcha G., Arenas E., Alberch J., Ogren S.O., Ibáñez C.F. Disruption of EphA/ephrin-a signaling in the nigrostriatal system reduces dopaminergic innervation and dissociates behavioral responses to amphetamine and cocaine. Mol. Cell. Neurosci. 2004, 26:418-428.
39. Souza R.P., Romano-Silva M.A., Lieberman J.A., Meltzer H.Y., MacNeil L.T., Culotti J.G., Kennedy J.L., Wong A.H. Genetic association of the GDNF alpha-receptor genes with schizophrenia and clozapine response. J. Psychiatr. Res. 2010, 44:700-706.
40. Syed Z., Dudbridge F., Kent L. An investigation of the neurotrophic factor genes GDNF, NGF, and NT3 in susceptibility to ADHD. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2007, 144B:375-378.
41. Trupp M., Belluardo N., Funakoshi H., Ibáñez C.F. Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS. J. Neurosci. 1997, 17:3554-3567.
42. Uchida S., Hara K., Kobayashi A., Otsuki K., Yamagata H., Hobara T., Suzuki T., Miyata N., Watanabe Y. Epigenetic status of Gdnf in the ventral striatum determines susceptibility and adaptation to daily stressful events. Neuron 2011, 69:359-372.
43. Westergaard U.B., Sørensen E.S., Hermey G., Nielsen M.S., Nykjaer A., Kirkegaard K., Jacobsen C., Gliemann J., Madsen P., Petersen C.M. Functional organization of the sortilin Vps10p domain. J. Biol. Chem. 2004, 279:50221-50229.
44. Willnow T.E., Petersen C.M., Nykjaer A. VPS10P-domain receptors - regulators of neuronal viability and function. Nat. Rev. Neurosci. 2008, 9:899-909.
45. Yu T., Scully S., Yu Y., Fox G.M., Jing S., Zhou R. Expression of GDNF family receptor components during development: implications in the mechanisms of interaction. J. Neurosci. 1998, 18:4684-4696.